Trials / Unknown
UnknownNCT06307028
Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P)
Sistas Informing Sistas on Topics About AIDS and Prevention
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
In this project, the investigators will provide a new HIV prevention training and empowerment sessions to Black women in Washington D.C. who are at high risk for getting HIV. This training is tailored to the experience of Black women and seeks to reduce the high HIV transmission rates in the Black community.
Detailed description
Experienced facilitators will implement two cycles of six 3-hour sessions with up to 15 participants per cycle while expert panelists observe. After each session, participants and subject matter expert observers will complete brief surveys. Surveys following each session include closed and open-ended measures: six items rating how well the session conveyed core information (e.g., I am confident I can communicate more effectively \[Session 3\]; I have a better understanding of the effects of alcohol on making sexual choices, \[Session 4\]) and single-item scales to evaluate the facilitator's performance and the session overall. In open-ended measures, respondents will be prompted to elaborate on their survey responses to identify ways the session could be improved.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | SISTA-P Intervention | This intervention is a small group discussion designed specifically for Black women. The sessions cover topics including: self pride and self-care; HIV \& PrEP education; assertiveness skills training; coping skills; skills practice; and barriers and facilitators to HIV prevention and PrEP. |
Timeline
- Start date
- 2024-01-08
- Primary completion
- 2024-07-01
- Completion
- 2024-08-31
- First posted
- 2024-03-12
- Last updated
- 2024-03-12
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06307028. Inclusion in this directory is not an endorsement.